CHARDAN CAPITAL MARKETS LLC - 28 Jun 2024 Form 4 Insider Report for ANEW Medical, Inc. (KLTO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jul 2024, 18:34:54 UTC
Prior SEC filing
01 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Chardan Capital Markets LLC, By: /s/ Steven Urbach, Manager

Key filing fact

CHARDAN CAPITAL MARKETS LLC filed Form 4 for ANEW Medical, Inc. (KLTO) on 02 Jul 2024.

Key facts

  • This page summarizes CHARDAN CAPITAL MARKETS LLC's Form 4 filing for ANEW Medical, Inc. (KLTO).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2024, 18:34.

Change

  • Previous filing in this sequence was filed on 01 Jul 2024.
  • Current net transaction value: -$725,162.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WENA transaction

Common Stock

Sale

Transaction value
$119,103
Shares
-47,000
Change %
-2.9%
Price
$2.53
Shares after
1,579,500
Date
28 Jun 2024
Ownership
Direct
Footnotes
F1, F2
WENA transaction

Common Stock

Sale

Transaction value
$237,618
Shares
-115,136
Change %
-7.3%
Price
$2.06
Shares after
1,464,364
Date
01 Jul 2024
Ownership
Direct
Footnotes
F2, F3
WENA transaction

Common Stock

Sale

Transaction value
$368,442
Shares
-180,000
Change %
-12%
Price
$2.05
Shares after
1,284,364
Date
02 Jul 2024
Ownership
Direct
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.38 to $2.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Footnote F2

This Form 4 is being filed by Chardan Capital Markets LLC ("CCM"). Chardan Securities LLC ("Chardan Securities") is the sole Class A Member and 99% owner of CCM and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Jonas Grossman, Steven Urbach and Kerry Propper is a member of Chardan Securities, and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Mr. Grossman, Mr. Urbach and Mr. Propper disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.80 to $2.495, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.90 to $2.30, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .